Scinai Immunotherapeutics OverviewScinai Immunotherapeutics Net Income
Profitability analysis for SCNI.
Quarterly Net Income
$3.57M
↑ 330.3% YoY
As of Mar 2026
Annual Net Income (TTM)
-$3.19M
↓ 173.14% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...